These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36525235)

  • 21. MiR-137 targets and regulates E2F7 to suppress progression of glioma cells.
    Li J; Gu J; Wang J; You A; Zhang Y; Rao G; Li S; Ge X; Zhang K; Wu X; Cheng L; Zhu M; Wang D
    Folia Neuropathol; 2022; 60(3):346-354. PubMed ID: 36382488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis.
    Pan X; Li D; Huo J; Kong F; Yang H; Ma X
    Cell Death Dis; 2018 Feb; 9(3):303. PubMed ID: 29467441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-424/E2F6 feedback loop modulates cell invasion, migration and EMT in endometrial carcinoma.
    Lu Z; Nian Z; Jingjing Z; Tao L; Quan L
    Oncotarget; 2017 Dec; 8(69):114281-114291. PubMed ID: 29371986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA H19 regulates the expression of its target gene HOXA10 in endometrial carcinoma through competing with miR-612.
    Zhang L; Wang DL; Yu P
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4820-4827. PubMed ID: 30070313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-425 involves in the development and progression of renal cell carcinoma by inhibiting E2F6.
    Cai Q; Zhao A; Ren LG; Chen J; Liao KS; Wang ZS; Zhang W
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6300-6307. PubMed ID: 30338798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA hsa_circ_0023404 promotes the proliferation, migration and invasion in endometrial cancer cells through regulating miR-217/MAPK1 axis.
    Chen Z; Huang M; You J; Lin Y; Huang Q; He C
    Eur J Med Res; 2022 Nov; 27(1):242. PubMed ID: 36352482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of differentiation antagonizing non-protein coding RNA exerts anti-tumor effect by up-regulating miR-214 in endometrial carcinoma.
    Sun J; Gao S; Lu C
    Mol Cell Biochem; 2019 Oct; 460(1-2):9-15. PubMed ID: 31161373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
    Wang C; Li S; Xu J; Niu W; Li S
    Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA SNHG8 participates in the development of endometrial carcinoma through regulating c-MET expression by miR-152.
    Yang CH; Zhang XY; Zhou LN; Wan Y; Song LL; Gu WL; Liu R; Ma YN; Meng HR; Tian YL; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1629-1637. PubMed ID: 29630089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
    Yin D; Lu X
    Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Lnc-OC1 Induced Cell Apoptosis and Decreased Cell Viability by Releasing miR-34a and Inhibiting PD-L1 in Endometrial Carcinoma.
    Liu Y; Chang Y; Cai YX
    Reprod Sci; 2020 Oct; 27(10):1848-1856. PubMed ID: 32748220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CISD2 transcriptional activated by transcription factor E2F7 promotes the malignant progression of cervical cancer.
    Wang L; Wang Y; Wang C; Yang K; Ye G
    J Mol Histol; 2023 Oct; 54(5):489-498. PubMed ID: 37615745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer.
    Yuan S; Xiang Y; Wang G; Zhou M; Meng G; Liu Q; Hu Z; Li C; Xie W; Wu N; Wu L; Cai T; Ma X; Zhang Y; Yu Z; Bai L; Li Y
    Mol Oncol; 2019 Apr; 13(4):840-856. PubMed ID: 30614188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma.
    Liang R; Xiao G; Wang M; Li X; Li Y; Hui Z; Sun X; Qin S; Zhang B; Du N; Liu D; Ren H
    Biomed Pharmacother; 2018 Nov; 107():1434-1446. PubMed ID: 30257360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA (lncRNA) HOXB-AS3 promotes cell proliferation and inhibits apoptosis by regulating ADAM9 expression through targeting miR-498-5p in endometrial carcinoma.
    Xing Y; Sun X; Li F; Jiang X; Jiang A; Li X; Lv R; Shao L
    J Int Med Res; 2021 Jun; 49(6):3000605211013548. PubMed ID: 34187214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA-ZXF1 stabilizes P21 expression in endometrioid endometrial carcinoma by inhibiting ubiquitination-mediated degradation and regulating the miR-378a-3p/PCDHA3 axis.
    Kong D; Hou Y; Li W; Ma X; Jiang J
    Mol Oncol; 2022 Feb; 16(3):813-829. PubMed ID: 33751805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LncRNA AL161431.1 targets miR-1252-5p and facilitates cellular proliferation and migration via MAPK signaling in endometrial carcinoma.
    Gu ZR; Liu W
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2294-2302. PubMed ID: 32196580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non‑coding RNA SNHG12 regulates cell proliferation, invasion and migration in endometrial cancer by targeting miR‑4429.
    Cai P; Wu M; Zhang B; Wu S; Wei H; Wei L
    Mol Med Rep; 2020 Oct; 22(4):2842-2850. PubMed ID: 32945395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.